Lok Sabha Passes the Disaster Management (Amendment) Bill, 2024  ||  NCLAT: Can’t Bar Petition u/s 7 of IBC for Default Committed Prior to S.10A Period  ||  NCLAT: Secured Creditor to Pay Liquidator's Fees Under Regulations if Option u/s 52 IBC Exercised  ||  Bom. HC: Authority Processing Duty Credit Scrip Application is the Adjudicating Authority for Appeals  ||  SC: Matters Exclusively Within Jurisdiction of Statutory Authorities are Not Arbitrable  ||  SC: Wife Not Filing Complaint of Cruelty for Years Doesn’t Mean There Was No Cruelty  ||  SC: Gift Deed Conditioned Upon Rendering of Services Without Remuneration is Unconstitutional  ||  SC: Can’t Invoke Preventive Detention against Every Alleged Breach of Peace  ||  SC: Mere Allegations of Harassment Not Enough to Hold Accused Guilty of Abetment of Suicide  ||  SC: No Registration of Further Suits against Places of Worship till Further Orders    

SEBI Imposes Rs. 22 Crore fine on Aurobindo Pharma for Insider Trading - (24 Sep 2019)

CAPITAL MARKET

Securities and Exchange Board of India has imposed a fine of Rs. 22.7 crore on Aurobindo Pharma Ltd., its promoters and related entities for insider trading between July, 2008 to March, 2009.

Tags : SECURITIES AND EXCHANGE BOARD OF INDIA   AUROBINDO PHARMA LTD.  SEBI  

Share :        

Disclaimer | Copyright 2024 - All Rights Reserved